Boston, MA—August 18, 2009
CenterWatchhas entered into a three-year partnership to share its clinical trials listing database with TrialX, a health information technology startup focused on helping patients more easily and rapidly connect with relevant clinical trials worldwide.
Investigators and patients can find the same listings on www.centerwatch.com and www.trialx.com.
“One of CenterWatch’s fundamental objectives is to ensure that patients have the access they need to the thousands of clinical trials going on around the world,” says Chris Pooley, senior vice president of CenterWatch. “Likewise, it’s important that investigators have as many avenues as possible for patient recruitment. Our partnership with TrialX helps to accomplish both those goals.”
Through TrialX’s integration with a host of online services including social media sites like Twitter and YouTube, internet health portals such as Google Health and Microsoft HealthVault, and its soon-to-be released iPhone application, investigators’ studies will be exposed to a wider, targeted patient population while patients will gain access to clinical trials in hundreds of disease categories.
“TrialX is excited to partner with CenterWatch,” says Vivek Garg, co-founder of TrialX. “This agreement will allow our site to receive current, accurate clinical trials information which will ultimately support our mission to help patients find trials that match their health conditions in an easy and timely manner.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.